IRIS
VIDILI, Gianpaolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.127
AS - Asia 2.836
SA - Sud America 1.684
EU - Europa 1.621
Continente sconosciuto - Info sul continente non disponibili 166
AF - Africa 115
OC - Oceania 13
Totale 11.562
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.915
BR - Brasile 1.492
SG - Singapore 1.265
CN - Cina 692
IT - Italia 482
UA - Ucraina 311
VN - Vietnam 226
HK - Hong Kong 200
DE - Germania 177
FR - Francia 130
GB - Regno Unito 98
SE - Svezia 91
FI - Finlandia 88
CA - Canada 81
RU - Federazione Russa 73
BD - Bangladesh 70
AR - Argentina 65
IN - India 51
TR - Turchia 51
IQ - Iraq 49
MX - Messico 43
EC - Ecuador 33
ID - Indonesia 33
ZA - Sudafrica 31
MA - Marocco 30
UZ - Uzbekistan 28
CO - Colombia 25
PL - Polonia 25
JP - Giappone 24
VE - Venezuela 22
PK - Pakistan 21
BE - Belgio 17
HN - Honduras 17
AT - Austria 16
CZ - Repubblica Ceca 16
ES - Italia 16
KR - Corea 16
RO - Romania 15
LT - Lituania 14
NL - Olanda 14
AU - Australia 12
CR - Costa Rica 12
JM - Giamaica 12
KE - Kenya 12
CL - Cile 11
JO - Giordania 11
UY - Uruguay 11
AE - Emirati Arabi Uniti 10
PY - Paraguay 10
CI - Costa d'Avorio 9
SA - Arabia Saudita 9
AL - Albania 8
AZ - Azerbaigian 8
BO - Bolivia 8
LB - Libano 7
NP - Nepal 7
PE - Perù 7
TN - Tunisia 7
GP - Guadalupe 6
GT - Guatemala 6
IL - Israele 6
KZ - Kazakistan 6
NI - Nicaragua 6
SV - El Salvador 6
DO - Repubblica Dominicana 5
EG - Egitto 5
MY - Malesia 5
OM - Oman 5
BN - Brunei Darussalam 4
CH - Svizzera 4
CW - ???statistics.table.value.countryCode.CW??? 4
DZ - Algeria 4
EE - Estonia 4
IR - Iran 4
KG - Kirghizistan 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BH - Bahrain 3
KW - Kuwait 3
MN - Mongolia 3
NG - Nigeria 3
PA - Panama 3
PR - Porto Rico 3
RS - Serbia 3
XK - ???statistics.table.value.countryCode.XK??? 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BM - Bermuda 2
BS - Bahamas 2
CY - Cipro 2
ET - Etiopia 2
GE - Georgia 2
IE - Irlanda 2
LV - Lettonia 2
PH - Filippine 2
PT - Portogallo 2
QA - Qatar 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TG - Togo 2
Totale 11.380
Salva come PNG Salva come JPEG
Città #
Dallas 1.294
Singapore 656
San Jose 461
Chandler 420
Ashburn 379
Council Bluffs 212
Hong Kong 195
Beijing 193
Jacksonville 178
Santa Clara 175
Princeton 148
Columbus 113
São Paulo 108
Lauterbourg 86
Nanjing 82
Ho Chi Minh City 78
Sassari 72
Dearborn 69
Milan 67
Los Angeles 64
New York 61
Ann Arbor 57
Shanghai 57
Hanoi 54
Belo Horizonte 53
Rio de Janeiro 53
Helsinki 48
Wilmington 45
Boardman 31
Moscow 30
Brasília 29
Nanchang 28
Shenyang 26
Tashkent 25
Orem 24
Curitiba 23
Munich 23
Tokyo 23
Rome 22
Tianjin 21
Woodbridge 21
Atlanta 20
Brooklyn 20
Houston 20
Montreal 20
Nuremberg 20
Porto Alegre 20
Toronto 20
Warsaw 20
Frankfurt am Main 19
Changsha 17
London 17
Brno 16
Johannesburg 16
Miano 16
Naples 16
San Francisco 16
Brussels 15
Buffalo 15
Denver 15
Mountain View 15
Baghdad 14
Cagliari 14
Guangzhou 14
Guayaquil 14
Seoul 14
Salvador 13
Chicago 12
Hebei 12
Nairobi 12
Phoenix 12
Santo André 12
Stockholm 12
Amman 11
Ankara 11
Campo Grande 11
Chennai 11
Guarulhos 11
Izmir 11
Jiaxing 11
Jinan 11
Montevideo 11
Ribeirão Preto 11
Sarapul 11
The Dalles 11
Vienna 11
Andover 10
Bogotá 10
Campinas 10
Franca 10
Mexico City 10
Ningbo 10
Ottawa 10
Poplar 10
Recife 10
Seattle 10
The Villages 10
Washington 10
Abidjan 9
Betim 9
Totale 6.593
Salva come PNG Salva come JPEG
Nome #
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis 362
Bedside ultrasonography (US), Echoscopy and US point of care as a new kind of stethoscope for Internal Medicine Departments: the training program of the Italian Internal Medicine Society (SIMI). 202
Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells 200
INVECCHIAMENTO E SISTEMA ENDOCRINO.LA SOMATOPAUSA, LA ADRENOPAUSA, LE MALATTIE DELLA TIROIDE 190
Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans 190
Evaluation of EZH2 expression in hepatitis B patients 183
HEPATOCELLULAR CARCINOMA DEVELOPMENT IN A PATIENT WITH HCV INFECTION AFTER ERADICATION WITH DIRECT-ACTING ANTIVIRAL AGENTS 182
Characterization of focal liver lesions with contrast-enhanced ultrasound. 181
Clinical history of cancer-associated splanchnic vein thrombosis 174
The burden of HIV-Associated neurocognitive disorder (HAND) in post-HAART era: Amultidisciplinary review of the literature 171
Targeted therapies in cholangiocarcinoma: emerging evidence from clinical trials 169
Long-term Clinical Outcomes of Splanchnic Vein Thrombosis Results of an International Registry 167
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis 167
Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria phenotype in patients with splanchnic vein thrombosis. 167
Clinical pattern of celiac disease in a population residing in North Sardinia (Italy) 162
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice 161
Functionalized multiwalled carbon nanotubes as ultrasound contrast agents 156
Immune compatible cystine-functionalized superparamagnetic iron oxide nanoparticles as vascular contrast agents in ultrasonography 155
Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease 154
Comparison of 2D Shear Wave Elastography and Transient Elastography in Non-Invasive Evaluation of Liver Fibrosis in Hepatitis C Virus-Related Chronic Liver Disease 153
Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications. 152
A Case of thyroid metastasis from pancreatic cancer: case report and literature review 151
Clinical presentation, diagnosis, and staging of cholangiocarcinoma 147
Effect of Probiotic Use on Adverse Events in Adult Patients with Inflammatory Bowel Disease: a retrospective Cohort Study 144
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma 143
Fitz-Hugh-Curtis-syndrome mimicking acute cholecystitis: value of new ultrasound findings in the differential diagnosis 142
Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines in vitro and AKT-driven hepatocarcinogenesis in mice 142
Methotrexate therapy is not associated with increased liver stiffness and significant liver fibrosis in rheumatoid arthritis patients: a cross-sectional controlled study with real-time two-dimensional shear wave elastography 141
Diagnostic features of real-time contrast-enhanced ultrasound in focal nodular hyperplasia of the liver 141
Antithrombotic treatment of splanchnic vein thrombosis: Results of an international registry 140
Experience of high frequency ultrasound in rare scalp pathology 138
Red Cell Distribution Width as a Predictor of Survival in Patients with Hepatocellular Carcinoma 133
Characteristics and outcome of anti‐hepatitis D virus positive patients with hepatocellular carcinoma 133
Focal nodular hyperplasia: new findings at Doppler ultrasonography 133
Common Variable Immunodeficiency and Selective IgA Deficiency: Focus on Autoimmune Manifestations and Their Pathogenesis 132
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 131
Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter 130
HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma 128
Functionalized multiwalled carbon nanotubes as ultrasound contrast agents. 128
Surgical treatment of chronic multivascular mesenteric ischemia in a patient with antiphospholipid syndrome, abdominal aortic aneurism, and renal cancer: when planning overwhelms complexity Ann Ital Chir. 2016 Dec 20;5. pii: S2239253X16026104. PMID: 27941240 125
Prevalence and risk factors of moderate to severe hepatic steatosis in patients with rheumatoid arthritis: an ultrasonography cross-sectional case–control study 123
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry 123
Low Rate of Intrahospital Deep Venous Thrombosis in Acutely Ill Medical Patients: Results From the AURELIO Study 121
HCC: Identificazione e caratterizzazione ecografica 120
The safety of Sonovue® in abdominal applications: Retrospective analysis of 23188 investigations 119
Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis 118
Safety and efficacy of low-dose fondaparinux (1.5 mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: the FONDAIR study 112
Sorafenib and locoregional treatment in patients with stage B and stage C HCC: Sardinian experience 109
Usefulness of ultrasound in the diagnosis of peritoneal tuberculosis 109
Diagnosis and management of hepatic focal nodular hyperplasia. Journal of Ultrasound 108
Trapianto di fegato 108
Contrast-enhanced ultrasonography features of extramedullary hematopoiesis presenting as a presacral mass: an update of the literature. 107
Renal hemodynamics and renoprotection 107
The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria. 106
Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience 106
Prothrombotic and inflammatory markers in elderly patients with non-alcoholic hepatic liver disease before and after weight loss: A pilot study 104
A nomogram-based prognostic model for advanced hepatocellular carcinoma patients treated with sorafenib: A multicenter study 104
Surveillance as determinant of long-term survival in non-transplanted hepatocellular carcinoma patients 103
Inverse association between glucose‒6‒phosphate dehydrogenase deficiency and hepatocellular carcinoma 102
RASi therapy in the renal haemodynamic in the course of proteinuric chronic nephropathy 101
Usefulness of ultrasound in the diagnosis of peritoneal tuberculosis 101
Identification of clinical phenotypes and related survival in patients with large hccs 99
Ipertensione portale: aspetti eco-color-Doppler 98
Doppler US and contrast-enhanced perfusional angiosonography in hepatocellular carcinoma 97
Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival 97
The changing scenario of hepatocellular carcinoma in Italy: an update 96
Gastrointestinal Ultrasound in Emergency Setting 96
Pathophysiological roles, molecular interactions and clinical implications of long non-coding RNA CCAT2 in human cancer 95
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy 95
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database 95
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study 91
Microplastics and nanoplastics in cardiovascular disease—a narrative review with worrying links 90
Infectious Pneumonia and Lung Ultrasound: A Review 89
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection 89
Fatty Acid Synthase Promotes Hepatocellular Carcinoma Growth via S-Phase Kinase-Associated Protein 2/p27KIP1 Regulation 89
SIUMB guidelines and recommendations for the correct use of ultrasound in the management of patients with focal liver disease 89
Surgical treatment of hepatocellular carcinoma in the era of COVID-19 pandemic: A comprehensive review of current recommendations 89
Monofocal hepatocellular carcinoma: How much does size matter? 89
Role of Lung Ultrasound in the Management of Patients with Suspected SARS-CoV-2 Infection in the Emergency Department 88
SIUMB recommendations for focal pancreatic lesions 88
Fisica, tecnica e principi di applicazione dell'eco-Doppler in medicina 85
linical pattern of celiac disease in a population residing in North Sardinia (Italy 84
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review 83
An ultrasound-based approach to jaundice from diagnosis to treatment 83
Non-invasive tools for the prediction of esophageal varices in cirrhosis: Can advanced ultrasound techniques spare endoscopy? 82
Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment 80
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 78
Pattern of macrovascular invasion in hepatocellular carcinoma 77
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care 75
Subclinical hyperthyroidism: The cardiovascular point of view 72
Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization 70
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 65
C-reactive protein-triglyceride glucose index as a predictor of heart failure risk in adults with MASLD: a prospective cohort study 44
SIUMB recommendations on the use of ultrasound in neoplastic lesions of the gallbladder and extrahepatic biliary tract 40
High systemic inflammation response index and increased cardiovascular risk and mortality in MASLD: A prospective cohort study 38
C-reactive protein-triglyceride glucose index as a predictor of heart failure risk in adults with MASLD: a prospective cohort study 21
null 10
null 5
Totale 11.562
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.543
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.543
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022293 0 0 0 5 4 4 20 13 24 13 68 142
2022/2023774 80 69 17 131 74 122 0 90 124 8 34 25
2023/2024326 35 14 11 13 38 18 13 43 2 5 25 109
2024/20252.942 43 50 139 90 153 100 176 532 1.044 411 121 83
2025/20264.398 203 1.033 611 625 441 221 593 105 183 220 135 28
2026/20271.390 104 278 405 603 0 0 0 0 0 0 0 0
Totale 11.562